Biomarkers For Recurrence Prediction Of Colorectal Cancer

  • Published: Nov 6, 2013
  • Earliest Priority: Jan 13 2011
  • Family: 10
  • Cited Works: 4
  • Cited by: 4
  • Cites: 5
  • Additional Info: Cited Works Published
Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

Methods for determining the likelihood of colorectal cancer (CRC) recurrence in a subject that involve measuring the expression level of two or more micro ribonucleic acids (miRNAs) in a biological sample comprising CRC tumor cells from said subject and using the normalized, measured expression levels to determine the likelihood of colorectal cancer recurrence for said subject. In the methods, the normalized expression levels of specific miRNAs are weighted by their contribution to CRC recurrence to calculate the likelihood of CRC recurrence. Kits for measuring the expression level of specific miRNAs that can be used in determining the likelihood of CRC recurrence are also provided.


Claims

Information currently unavailable.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Nov 6, 2013
  • Application: Jan 11, 2012
    CN CN 201280003647 A
  • Priority: Jan 11, 2012
    US US 2012/0020949 W
  • Priority: Jan 11, 2012
    US US 201213348098 A
  • Priority: Jan 13, 2011
    US US 201161432468 P

Download Citation


Sign in to the Lens

Feedback